·       通过为成功新药的研发企业提供一次性市场准入奖励解决目前新抗生素研发领域的市场失灵现象，同时确保全球都能公平地享受到研发成果。
· Address the market failure in the development of new antibiotics by introducing lump-sum market-entry rewards to developers of successful new drugs, while ensuring global access.